Ahmadi Nahid, Shahhosseini Soraya, H Shirazi Farshad, Farnam Golrokh, Zarghi Afshin
Department of Pharmaceutical Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Protein Technology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Iran J Pharm Res. 2022 Jun 3;21(1):e127041. doi: 10.5812/ijpr-127041. eCollection 2022 Dec.
Breast cancer is an invasive disease with a high prevalence among females. Despite various treatments, studies are still ongoing to find an effective treatment for this disease. This study aimed to synthesize a new series of diaryl benzo[d]imidazo[2,1-b]thiazole compounds containing aminoethoxy side chain and in vitro investigate their cytotoxicity on a human breast cancer cell line (MCF-7). Twelve derivatives (6a-6l) were synthesized from this scaffold, the structures of which were spectroscopically confirmed. The cytotoxic effects of the derivatives on the MCF-7 cell line were also assessed using the MTT assay. All these compounds showed a good inhibitory effect on the MCF-7 cell line, compared to that of tamoxifen. Compounds (6i) and (6j) showed higher cytotoxicity with relevant inhibitory effects of 81% and 73%, respectively.
乳腺癌是一种在女性中高发的侵袭性疾病。尽管有多种治疗方法,但仍在进行研究以寻找针对该疾病的有效治疗方案。本研究旨在合成一系列含有氨基乙氧基侧链的新型二芳基苯并[d]咪唑并[2,1-b]噻唑化合物,并在体外研究它们对人乳腺癌细胞系(MCF-7)的细胞毒性。从该骨架合成了十二种衍生物(6a - 6l),其结构经光谱确认。还使用MTT法评估了这些衍生物对MCF-7细胞系的细胞毒性作用。与他莫昔芬相比,所有这些化合物对MCF-7细胞系均表现出良好的抑制作用。化合物(6i)和(6j)表现出更高的细胞毒性,相关抑制率分别为81%和73%。